Cargando…
A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial
BACKGROUND: Infestation with the human head louse (Pediculus humanus capitis) occurs worldwide. Existing treatment options are limited, and reports of resistance to commonly used pediculicides have been increasing. In this trial we assessed the efficacy of a product containing a high (92%) concentra...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553415/ https://www.ncbi.nlm.nih.gov/pubmed/18783606 http://dx.doi.org/10.1186/1471-2334-8-115 |
_version_ | 1782159502997454848 |
---|---|
author | Heukelbach, Jorg Pilger, Daniel Oliveira, Fabíola A Khakban, Adak Ariza, Liana Feldmeier, Hermann |
author_facet | Heukelbach, Jorg Pilger, Daniel Oliveira, Fabíola A Khakban, Adak Ariza, Liana Feldmeier, Hermann |
author_sort | Heukelbach, Jorg |
collection | PubMed |
description | BACKGROUND: Infestation with the human head louse (Pediculus humanus capitis) occurs worldwide. Existing treatment options are limited, and reports of resistance to commonly used pediculicides have been increasing. In this trial we assessed the efficacy of a product containing a high (92%) concentration of the silicone oil dimeticone (identical in composition to NYDA(®)), as compared to a 1% permethrin lotion. METHODS: Randomized, controlled, observer blinded clinical trial. Participants were recruited from a poor urban neighbourhood in Brazil where pediculosis capitis was highly prevalent. To minimize reinfestation during the trial, participants (145 children aged 5–15 years with head lice infestations) were transferred to a holiday resort outside the endemic area for a period of 9 days. Two applications of dimeticone or 1% permethrin were done, seven days apart. Outcome measures were defined as cure (absence of vital head lice) after first application and before and after second applications, degree of itching, cosmetic acceptability, and clinical pathology. RESULTS: Overall cure rates were: day 2 – dimeticone 94.5% (95% CI: 86.6% – 98.5%) and permethrin 66.7% (95% CI: 54.6% – 77.3%; p < 0.0001); day 7 – dimeticone 64.4% (95% CI: 53.3% – 75.3%) and permethrin 59.7% (95% CI: 47.5% – 71.1%; p = 0.5); day 9 – dimeticone 97.2% (95% CI: 90.3% – 99.7%) and permethrin 67.6% (95% CI: 55.4%-78.2%); p < 0.0001). Itching was reduced similarly in both groups. Cosmetic acceptability was significantly better in the dimeticone group as compared to the permethrin group (p = 0.01). Two mild product-related incidents occurred in the dimeticone group. CONCLUSION: The dimeticone product is a safe and highly efficacious pediculicide. Due to its physical mode of action (interruption of the lice's oxygen supply of the central nervous system), development of resistance is unlikely. TRIAL REGISTRATION: Current Controlled Trials ISRCTN15117709. |
format | Text |
id | pubmed-2553415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25534152008-09-26 A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial Heukelbach, Jorg Pilger, Daniel Oliveira, Fabíola A Khakban, Adak Ariza, Liana Feldmeier, Hermann BMC Infect Dis Research Article BACKGROUND: Infestation with the human head louse (Pediculus humanus capitis) occurs worldwide. Existing treatment options are limited, and reports of resistance to commonly used pediculicides have been increasing. In this trial we assessed the efficacy of a product containing a high (92%) concentration of the silicone oil dimeticone (identical in composition to NYDA(®)), as compared to a 1% permethrin lotion. METHODS: Randomized, controlled, observer blinded clinical trial. Participants were recruited from a poor urban neighbourhood in Brazil where pediculosis capitis was highly prevalent. To minimize reinfestation during the trial, participants (145 children aged 5–15 years with head lice infestations) were transferred to a holiday resort outside the endemic area for a period of 9 days. Two applications of dimeticone or 1% permethrin were done, seven days apart. Outcome measures were defined as cure (absence of vital head lice) after first application and before and after second applications, degree of itching, cosmetic acceptability, and clinical pathology. RESULTS: Overall cure rates were: day 2 – dimeticone 94.5% (95% CI: 86.6% – 98.5%) and permethrin 66.7% (95% CI: 54.6% – 77.3%; p < 0.0001); day 7 – dimeticone 64.4% (95% CI: 53.3% – 75.3%) and permethrin 59.7% (95% CI: 47.5% – 71.1%; p = 0.5); day 9 – dimeticone 97.2% (95% CI: 90.3% – 99.7%) and permethrin 67.6% (95% CI: 55.4%-78.2%); p < 0.0001). Itching was reduced similarly in both groups. Cosmetic acceptability was significantly better in the dimeticone group as compared to the permethrin group (p = 0.01). Two mild product-related incidents occurred in the dimeticone group. CONCLUSION: The dimeticone product is a safe and highly efficacious pediculicide. Due to its physical mode of action (interruption of the lice's oxygen supply of the central nervous system), development of resistance is unlikely. TRIAL REGISTRATION: Current Controlled Trials ISRCTN15117709. BioMed Central 2008-09-10 /pmc/articles/PMC2553415/ /pubmed/18783606 http://dx.doi.org/10.1186/1471-2334-8-115 Text en Copyright © 2008 Heukelbach et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Heukelbach, Jorg Pilger, Daniel Oliveira, Fabíola A Khakban, Adak Ariza, Liana Feldmeier, Hermann A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial |
title | A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial |
title_full | A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial |
title_fullStr | A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial |
title_full_unstemmed | A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial |
title_short | A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial |
title_sort | highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553415/ https://www.ncbi.nlm.nih.gov/pubmed/18783606 http://dx.doi.org/10.1186/1471-2334-8-115 |
work_keys_str_mv | AT heukelbachjorg ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT pilgerdaniel ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT oliveirafabiolaa ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT khakbanadak ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT arizaliana ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT feldmeierhermann ahighlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT heukelbachjorg highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT pilgerdaniel highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT oliveirafabiolaa highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT khakbanadak highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT arizaliana highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial AT feldmeierhermann highlyefficaciouspediculicidebasedondimeticonerandomizedobserverblindedcomparativetrial |